These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33410583)

  • 1. Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand.
    Duffy E; Arroll N; Beasley R; Hills T
    Arthritis Rheumatol; 2021 May; 73(5):896-897. PubMed ID: 33410583
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
    Mendel A; Bernatsky S; Askanase A; Bae SC; Clarke AE; Costedoat-Chalumeau N; Gladman DD; Gordon C; Hanly J; Jacobsen S; Kalunian K; Mak A; Mosca M; Pons-Estel BA; Ruiz-Irastorza G; Urowitz M; Vinet É
    Ann Rheum Dis; 2021 Feb; 80(2):1-2. PubMed ID: 32586918
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
    Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
    Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
    Spila Alegiani S; Crisafulli S; Giorgi Rossi P; Mancuso P; Salvarani C; Atzeni F; Gini R; Kirchmayer U; Belleudi V; Kurotschka PK; Leoni O; Ludergnani M; Ferroni E; Baracco S; Massari M; Trifirò G;
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI25-SI36. PubMed ID: 33856453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hydroxychloroquine in Japan.
    Kishimoto M; Deshpande GA; Yokogawa N; Buyon JP; Okada M
    J Rheumatol; 2012 Jun; 39(6):1296. PubMed ID: 22661421
    [No Abstract]   [Full Text] [Related]  

  • 7. Navigating COVID-19 in the developing world.
    Hodkinson B; Singh P; Gcelu A; Bautista-Molano W; Pons-Estel G; Alpízar-Rodríguez D
    Clin Rheumatol; 2020 Jul; 39(7):2039-2042. PubMed ID: 32462422
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
    Pileggi GS; Ferreira GA; Reis APMG; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa ED; Borba EF; Brito DCSE; Duarte ÂLBP; Santo RCE; Fernandes PR; Guimarães MP; Gomes KWP; Kakehasi AM; Klumb EM; Lanna CCD; Marques CDL; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Junior LFR; Sampaio CSJC; Sampaio VS; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Pinheiro MM
    Adv Rheumatol; 2021 Oct; 61(1):60. PubMed ID: 34620246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety.
    Cornet A; Andersen J; Tani C; Mosca M
    Lupus Sci Med; 2021 Apr; 8(1):. PubMed ID: 33875571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine and hydroxychloroquine - safety profile of potential COVID-19 drugs from the rheumatologist's perspective.
    Majewski D; Majewska KA; Naskręcka M; Grygiel-Górniak B
    Ann Agric Environ Med; 2021 Mar; 28(1):122-126. PubMed ID: 33775077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study.
    Ziadé N; Hmamouchi I; El Kibbi L; Abdulateef N; Halabi H; Abutiban F; Hamdi W; El Rakawi M; Eissa M; Masri B
    Clin Rheumatol; 2020 Nov; 39(11):3205-3213. PubMed ID: 32996071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to manage rheumatic patients during the coronavirus pandemic.
    Parisi S; Ditto MC; Finucci A; Fusaro E
    Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
    Nuño L; Novella Navarro M; Bonilla G; Franco-Gómez K; Aguado P; Peiteado D; Monjo I; Tornero C; Villalba A; Miranda-Carus ME; De Miguel E; Bogas P; Castilla-Plaza A; Bernad-Pineda M; García-Lorenzo E; Rodríguez-Araya T; Balsa A
    Ann Rheum Dis; 2020 Dec; 79(12):1659-1661. PubMed ID: 32606046
    [No Abstract]   [Full Text] [Related]  

  • 14. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.
    Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covid-19 treatment update: follow the scientific evidence.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
    Mehta B; Moezinia CJ; Jannat-Khah D; Gibofsky A; Tornberg H; Pearce-Fisher D; Goodman SM; Salmon JE; Ibrahim S
    J Clin Rheumatol; 2020 Sep; 26(6):224-228. PubMed ID: 32694358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Evaluation during the Covid-19 Pandemic.
    Rome BN; Avorn J
    N Engl J Med; 2020 Jun; 382(24):2282-2284. PubMed ID: 32289216
    [No Abstract]   [Full Text] [Related]  

  • 18. Should coronavirus disease 2019 concern rheumatologists?
    Kucharz EJ
    Pol Arch Intern Med; 2020 Aug; 130(7-8):655-661. PubMed ID: 32426957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease].
    Malek SA; Bouchti IE
    Pan Afr Med J; 2020; 35(Suppl 2):134. PubMed ID: 33193949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine shortages during the COVID-19 pandemic.
    Mendel A; Bernatsky S; Thorne JC; Lacaille D; Johnson SR; Vinet É
    Ann Rheum Dis; 2021 Mar; 80(3):e31. PubMed ID: 32434820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.